DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Transplanted human multipotent stromal cells reduce acute tongue fibrosis in rats

Journal Article · · Laryngoscope Investigative Otolaryngology
DOI: https://doi.org/10.1002/lio2.202 · OSTI ID:1481436
ORCiD logo [1]; ORCiD logo [2];  [2];  [2]; ORCiD logo [3]
  1. Department of Surgery, Division of Otolaryngology UC San Diego Health La Jolla CA
  2. From the Department of Head and Neck Surgery, UCLA David Geffen School of Medicine Los Angeles California U.S.A.
  3. From the Department of Head and Neck Surgery, UCLA David Geffen School of Medicine Los Angeles California U.S.A., Research Service Greater Los Angeles VA Healthcare System Los Angeles California U.S.A.

Background Tongue fibrosis resulting from head and neck cancer, surgery, radiation, chemotherapy, or a combination thereof devastates one's quality of life. Therapeutic options are limited. Here we investigate human bone marrow–derived multipotent stromal cells (MSC) as a novel injectable treatment for post‐injury tongue fibrosis. Methods MSCs were grown in culture. Eighteen athymic rats underwent unilateral partial glossectomy. After two weeks for scar formation, a single injection was performed in the tongue scar. Three treatment groups were studied: low and high concentration MSC, and control media injection. Tongues were harvested for evaluation at three weeks post‐treatment. Results Dense fibrosis was achieved in control animals at five weeks. High concentration MSC reduced cross sectional scar burden ( P = .007) and pathologic score for inflammation and fibrosis. Conclusion This study establishes the feasibility of a novel rodent tongue fibrosis model, and begins to assess the utility of human MSCs to reduce scar burden. Level of Evidence N/a

Sponsoring Organization:
USDOE
OSTI ID:
1481436
Journal Information:
Laryngoscope Investigative Otolaryngology, Journal Name: Laryngoscope Investigative Otolaryngology Journal Issue: 6 Vol. 3; ISSN 2378-8038
Publisher:
Wiley Blackwell (John Wiley & Sons)Copyright Statement
Country of Publication:
Country unknown/Code not available
Language:
English

References (32)

Muscle Tissue Engineering for Partial Glossectomy Defects journal September 2003
Successful myoblast transplantation in rat tongue reconstruction journal January 2006
Mesenchymal stem cells journal September 1991
Autologous myoblasts attenuate atrophy and improve tongue force in a denervated tongue model: A pilot study: Serum Protein Profiling for HNSCC journal October 2013
Videofluoroscopic Validation of a Translational Murine Model of Presbyphagia journal March 2015
25 Years of Dysphagia Rehabilitation: What Have We Done, What are We Doing, and Where are We Going? journal January 2017
Control of scarring in adult wounds by neutralising antibody to transforming growth factor β journal January 1992
Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer journal May 2002
Allogeneic Mesenchymal Precursor Cell Therapy to Limit Remodeling After Myocardial Infarction: The Effect of Cell Dosage journal March 2009
Impact of Timing and Dose of Mesenchymal Stromal Cell Therapy in a Preclinical Model of Acute Myocardial Infarction journal May 2013
Long-term prevalence of oropharyngeal dysphagia in head and neck cancer patients: Impact on quality of life journal December 2007
Effects of exercise on swallowing and tongue strength in patients with oral and oropharyngeal cancer treated with primary radiotherapy with or without chemotherapy journal May 2014
Factors Associated With Long-Term Dysphagia After Definitive Radiotherapy for Locally Advanced Head-and-Neck Cancer journal February 2009
Multimodality Noninvasive Imaging Demonstrates In Vivo Cardiac Regeneration After Mesenchymal Stem Cell Therapy journal November 2006
Oropharyngeal Dysphagia after Stroke: Incidence, Diagnosis, and Clinical Predictors in Patients Admitted to a Neurorehabilitation Unit journal September 2009
In vivo autologous recellularization of a tissue-engineered heart valve: Are bone marrow mesenchymal stem cells the best candidates? journal August 2007
Mesenchymal stem/stromal cells as a pharmacological and therapeutic approach to accelerate angiogenesis journal August 2014
Dose–Response Relationship of Mesenchymal Stem Cell Transplantation and Functional Regeneration After Severe Skeletal Muscle Injury in Rats journal March 2009
Transplantation of Amniotic Scaffold-Seeded Mesenchymal Stem Cells and/or Endothelial Progenitor Cells From Bone Marrow to Efficiently Repair 3-cm Circumferential Urethral Defect in Model Dogs journal January 2018
Cardiomyoblast-like Cells Differentiated from Human Adipose Tissue-Derived Mesenchymal Stem Cells Improve Left Ventricular Dysfunction and Survival in a Rat Myocardial Infarction Model journal June 2010
Exercise, Obesity, and Cutaneous Wound Healing: Evidence from Rodent and Human Studies journal January 2014
Human Adipose Tissue Is a Source of Multipotent Stem Cells journal December 2002
Dysphagia following chemoradiation for locally advanced head and neck cancer journal March 2004
Tissue engineered muscle implantation for tongue reconstruction: A preliminary report journal October 2003
Scar–free healing: from embryonic mechanisms to adult therapeutic intervention journal May 2004
Allogeneic adipose stem cell therapy in acute myocardial infarction journal December 2013
Laryngeal advancement surgery improves swallowing function in a reversible equine dysphagia model: Laryngeal advancement improves swallowing in dysphagic horses journal May 2015
Reversal of Persistent Fibrosis in Aging by Targeting Nox4-Nrf2 Redox Imbalance journal April 2014
Fate of liposuctioned and purified autologous fat injections in the canine vocal fold journal January 1995
New insights into the heterogeneity and functional diversity of human mesenchymal stem cells journal March 2017
Change of Swallowing in Patients With Head and Neck Cancer After Concurrent Chemoradiotherapy journal January 2016
Development and Characterization of a Clinically Compliant Xeno-Free Culture Medium in Good Manufacturing Practice for Human Multipotent Mesenchymal Stem Cells journal October 2012